Protein‐polymer conjugates represent a dynamic class of hybrid materials that combine the inherent biological function and specificity of proteins with the versatile properties of synthetic polymers.
Antibody-based cancer therapies have clear advantages over chemotherapeutic drugs thanks to their high specificity and low risk of side effects. However, it can be difficult to identify targetable ...